Hyperphenylalaninaemia

15Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mutations within the gene for the hepatic enzyme phenylalanine hydroxylase (PAH) and those involving enzymes of pterin metabolism are associated with hyperphenylalaninaemia (HPA). Phenylketonuria (PKU) is caused by a severe deficiency in PAH activity and if left untreated leads to permanent central nervous system damage. Dietary restriction of phenylalanine (PHE) along with amino acid, vitamin and mineral supplements, started in the first weeks of life and continued through childhood, is an effective treatment and allows for normal cognitive development.

Cite

CITATION STYLE

APA

Walter, J. H., Lachmann, R. H., & Burgard, P. (2012). Hyperphenylalaninaemia. In Inborn Metabolic Diseases: Diagnosis and Treatment (pp. 251–264). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-15720-2_17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free